The first will be published in Drug Discovery Today and you can read the pre-print here.
‘OnePoint’ – combining OneNote and SharePoint to facilitate knowledge transfer
The identification and development of novel drugs requires a multidisciplinary team of individuals whose membership changes during the lifecycle of a project. Incomplete knowledge transfer across this team can be a barrier to effective decision-making and efficient drug discovery. We have deployed a new infrastructure supporting information storage and distribution within small teams using Microsoft's SharePoint™ server technology in conjunction with the desktop application OneNote™. This delivers a user-friendly collaborative workspace that is fast, flexible and carries a low training burden. Demand from drug project teams for this ‘solution’ has now resulted in site-wide deployment to over 500 people across research.
The second case study, available here, was done in collaboration with Microsoft. In this case Microsoft also produced a video, see below, which really brings OnePoint to life (need Silverlight installed to view).
Pfizer Boosts Efficiency by 15 Percent with Easy to Use, Shared Note-Taking Program
For the past 150 years, Pfizer has pioneered the development of some of the industry’s most innovative pharmaceutical products. In 2007, Pfizer applied this “out of the box” thinking to a pilot program designed to enhance efficiency and knowledge management across project teams, and potentially speed time-to-market for new products. The pilot brought together the simple, intuitive user interface of the Microsoft® Office OneNote® 2007 note-taking program with the robust document management technology of Microsoft Office SharePoint® Server 2007. As a result, pilot participants reported a significant decrease in the number of e-mail messages they send each day, and one group reported a 15 percent increase in efficiency. Overall, the 600 participants reported a 2 percent time savings per week, which represents a cost savings of approximately U.S.$2.25 million.